In this study, oral administration of HFD induced oxidative stress, lipid peroxidation, steatosis, and increased ALT and AST activities in rats, confirming the successful formation of an animal model of NAFLD. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.